Portugal joins EU-OPENSCREEN as a new member country

Portugal has joined the EU-OPENSCREEN ERIC as a new member country. The National Infrastructure for Chemical Biology and Genetics in Portugal (PT-OPENSCREEN) was recently included in the 2020 Portuguese Roadmap of Research Infrastructures. PT-OPENSCREEN is coordinated by the Institute for Health Research and Innovation of the University of Porto (i3S) and brings together the main research centres in the areas of chemistry and biology across the country. PT-OPENSCREEN coordinates the participation of Portugal in EU-OPENSCREEN.

The representing entity is the Fundação para a Ciência e a Tecnologia (FCT, I.P.). Portugal will be represented in the Assembly of Members by Marta Abrantes (FCT) and Prof. António Pombinho (i3S).

"These are really exciting times for Portuguese chemical biology research. We were able to establish a dynamic national infrastructure and we are now proud to join forces with the best European institutions in the field. I would like to thank the Portuguese Foundation for Science and Technology for their continuous support and EU-OPENSCREEN for welcoming us to the family," states Prof. António Pombinho.

"I am delighted that Portugal is joining EU-OPENSCREEN as a new member country. This is an important milestone. The Portuguese infrastructure initiative has come a long way since the kick-off meeting of PT-OPENSCREEN in July 2018. These excellent institutions and universities can now become members in our network of 24 European partner sites and implement EU-OPENSCREEN research projects by using our unique screening compound collections," states Bahne Stechmann, Head of Operations and Scientific Strategy.

"The Covid-19 pandemic has demonstrated how important collaborative, multidisciplinary research is. Portugal's chemical biology community will make an important contribution to EU-OPENSCREEN and the new institutes will be privileged partners in future EU-OPENSCREEN-led research projects," states Wolfgang Fecke, Director General of EU-OPENSCREEN.